Corcept Therapeutics | Ventes

Created with Highcharts 10.1.0Chart context menu86.6M102M120M138M155M173M188M
2022Q32023Q32024Q3


Sales Changement Date
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Alaunos Therapeutics USD 0 4K 2024-09
ANI Pharmaceuticals USD 190.6M 42.3M 2024-12
Ardelyx USD 116.13M 17.89M 2024-12
Aurora Cannabis CAD 88.2M 7.08M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
J&J USD 22.52B 49M 2024-12
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Merck USD 15.62B 1.03B 2024-12
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Pacira USD 187.25M 18.68M 2024-12
Pfizer USD 17.76B 61M 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
TG Therapeutics USD 108.18M 24.31M 2024-12



Corcept Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.